Veracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9.67 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.